Efficacy and Safety of Two Regimens of Maintenance Therapy in Children With Crohn Disease
Status:
Unknown status
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
The aim of the study is confirmation of efficacy of induction therapy with three doses of
infliximab In patients with Crohn disease aged 7-17 years, and comparison of efficacy and
safety of two regiment of maintenance therapy:
1. Infliximab with immunomodulation
2. Infliximab alone